3-(N,O-dimethylhydroxylaminocarbonyl)diphenylmethane | 422550-69-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(N,O-dimethylhydroxylaminocarbonyl)diphenylmethane
• 英文别名: 3-benzyl-N-methoxy-N-methyl-benzamide；N-methyl-N-methoxy-(3-benzyl)benzenecarboxamide；3-benzyl-N-methoxy-N-methylbenzamide
• CAS: 422550-69-4
• 化学式: C₁₆H₁₇NO₂
• 分子量: 255.316
• InChiKey: FMNRENIITHOJTP-UHFFFAOYSA-N

物化性质

• 沸点：
  423.7±24.0 °C(Predicted)
• 密度：
  1.107±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(N,O-dimethylhydroxylaminocarbonyl)diphenylmethane 在 叔丁基锂 、 三氟乙酸 作用下， 以 四氢呋喃 、 甲醇 、 正戊烷 为溶剂， 反应 72.25h， 生成 1-(3-Benzylphenyl)-1-(8-hydroxyquinolin-7-yl)methanone
  参考文献：
  名称：

  Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells

  摘要：

  Naphthyridine 7 inhibits the strand transfer of the integration process catalyzed by integrase with an IC50 of 10 nM and inhibits 95% of the spread of HIV-1 infection in cell culture at 0.39 muM. It does not exhibit cytotoxicity in cell culture at less than or equal to 12.5 muM and shows a good pharmacokinetic profile when dosed orally to rats. The antiviral activity of 7 and its effect on integration were confirmed using viruses with specific integrase mutations.

  DOI：

  10.1021/jm025553u
• 作为产物：
  描述：

  3-苯甲酰基-N-甲氧基-N-甲基苯甲酰胺 在 palladium 10% on activated carbon 高氯酸 、 氢气 作用下， 以 乙醇 为溶剂， 反应 24.0h， 生成 3-(N,O-dimethylhydroxylaminocarbonyl)diphenylmethane
  参考文献：
  名称：

  Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors

  摘要：

  某些氮杂萘基酮和多氮杂萘基酮，包括某些喹啉基和萘啉基酮，被描述为HIV整合酶的抑制剂和HIV复制的抑制剂。这些化合物在预防或治疗HIV感染以及治疗或延缓艾滋病发作方面是有用的，可以作为化合物或药学上可接受的盐，或作为药物组合物中的成分，可选地与其他抗病毒药物、免疫调节剂、抗生素或疫苗结合使用。还描述了治疗或延缓艾滋病发作的方法以及预防或治疗HIV感染的方法。

  公开号：

  US20050010048A1

文献信息

• Feedstocks to Pharmacophores: Cu-Catalyzed Oxidative Arylation of Inexpensive Alkylarenes Enabling Direct Access to Diarylalkanes
  作者：Aristidis Vasilopoulos、Susan L. Zultanski、Shannon S. Stahl

  DOI：10.1021/jacs.7b03387

  日期：2017.6.14

  A Cu-catalyzed method has been identified for selective oxidative arylation of benzylic C-H bonds with arylboronic esters. The resulting 1,1-diarylalkanes are accessed directly from inexpensive alkylarenes containing primary and secondary benzylic C-H bonds, such as toluene or ethylbenzene. All catalyst components are commercially available at low cost, and the arylboronic esters are either commercially

  已经确定了一种 Cu 催化的方法，用于苄基 CH 键与芳基硼酸酯的选择性氧化芳基化。所得的 1,1-二芳基烷烃可直接从含有伯和仲苄基 CH 键的廉价烷基芳烃（如甲苯或乙苯）中获得。所有催化剂组分均可以低成本商购获得，并且芳基硼酸酯可商购获得或容易从商购硼酸获得。强调了这些方法在药物化学应用中的潜在效用。
• AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS
  申请人：Merck & Co., Inc.

  公开号：EP1333831A2

  公开（公告）日：2003-08-13
• [EN] AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS<br/>[FR] AZA- ET POLYAZA-NAPHTALENYL CETONES UTILES EN TANT QU'INHIBITEURS DE L'INTEGRASE DU VIH
  申请人：MERCK & CO INC

  公开号：WO2002036734A2

  公开（公告）日：2002-05-10

  Certain aza- and polyaza-naphthalenyl ketones including certain quinolinyl and naphthyridinyl ketones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment or the delay in the onset of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.
• Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors
  申请人：Zhuang Linghang

  公开号：US20050010048A1

  公开（公告）日：2005-01-13

  Certain aza- and polyaza-naphthalenyl ketones including certain quinolinyl and naphthyridinyl ketones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment or the delay in the onset of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.

  某些氮杂萘基酮和多氮杂萘基酮，包括某些喹啉基和萘啉基酮，被描述为HIV整合酶的抑制剂和HIV复制的抑制剂。这些化合物在预防或治疗HIV感染以及治疗或延缓艾滋病发作方面是有用的，可以作为化合物或药学上可接受的盐，或作为药物组合物中的成分，可选地与其他抗病毒药物、免疫调节剂、抗生素或疫苗结合使用。还描述了治疗或延缓艾滋病发作的方法以及预防或治疗HIV感染的方法。
• Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells
  作者：Linghang Zhuang、John S. Wai、Mark W. Embrey、Thorsten E. Fisher、Melissa S. Egbertson、Linda S. Payne、James P. Guare,、Joseph P. Vacca、Daria J. Hazuda、Peter J. Felock、Abigail L. Wolfe、Kara A. Stillmock、Marc V. Witmer、Gregory Moyer、William A. Schleif、Lori J. Gabryelski、Yvonne M. Leonard、Joseph J. Lynch,、Stuart R. Michelson、Steven D. Young

  DOI：10.1021/jm025553u

  日期：2003.2.1

  Naphthyridine 7 inhibits the strand transfer of the integration process catalyzed by integrase with an IC50 of 10 nM and inhibits 95% of the spread of HIV-1 infection in cell culture at 0.39 muM. It does not exhibit cytotoxicity in cell culture at less than or equal to 12.5 muM and shows a good pharmacokinetic profile when dosed orally to rats. The antiviral activity of 7 and its effect on integration were confirmed using viruses with specific integrase mutations.